Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). RBC Life Sciences's share price for the quarter that ended in Jun. 2017 was $0.28. RBC Life Sciences's Shares Outstanding (EOP) for the quarter that ended in Jun. 2017 was 2.21 Mil. Therefore, RBC Life Sciences's market cap for the quarter that ended in Jun. 2017 was $0.62 Mil.
RBC Life Sciences's quarterly market cap
declined
from Dec. 2016 ($0.66 Mil) to Mar. 2017 ($0.55 Mil) but then
increased
from Mar. 2017 ($0.55 Mil) to Jun. 2017 ($0.62 Mil).
RBC Life Sciences's annual market cap
declined
from Dec. 2014 ($2.88 Mil) to Dec. 2015 ($0.55 Mil) but then
increased
from Dec. 2015 ($0.55 Mil) to Dec. 2016 ($0.66 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. RBC Life Sciences's Enterprise Value for Today is $0.00 Mil.
RBC Life Sciences (OTCPK:RBCL) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
RBC Life Sciences Market Cap Related Terms
RBC Life Sciences Market Cap Historical Data
* Premium members only.
The historical data trend for RBC Life Sciences's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, RBC Life Sciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RBC Life Sciences Market Cap vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, RBC Life Sciences's Market Cap distribution charts can be found below:
* The bar in red indicates where RBC Life Sciences's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
RBC Life Sciences's Market Cap for the fiscal year that ended in Dec. 2016 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RBC Life Sciences (RBCL) has a Market Cap of $0.00 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on RBC Life Sciences and its competitors.
Is RBC Life Sciences' Market Cap too high?
RBC Life Sciences' current Market Cap is $0.00 Mil.
How does RBC Life Sciences' Market Cap compare to SKVI and TISUQ?
RBC Life Sciences' Market Cap of $0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. The industry median Market Cap is 100.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Consumer Packaged Goods company?
The median Market Cap among Consumer Packaged Goods companies is 100.76, based on 2,041 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on RBC Life Sciences and its competitors. For the Consumer Packaged Goods industry, the median Market Cap is 100.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RBC Life Sciences's current Market Cap is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RBC Life Sciences stock overvalued right now?
RBC Life Sciences (RBCL) has a current Market Cap of $0.00 Mil. The current Market Cap is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For RBC Life Sciences (RBCL), the current Market Cap is $0.00 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
RBC Life Sciences Inc, through its subsidiaries, is engaged in marketing and distribution of nutritional supplements and personal care products. Its products include herbal formulas, vitamins, minerals, antioxidants, and skin, hair and body care products. It also markets its Nutritional Products in certain international markets through license arrangements. In addition to its Nutritional Products, the company also markets a line of wound care products under the MPM Medical brand name through a U.S. subsidiary.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RBCL has been successfully added to your 